Noven patents expiration
1. Minivelle patents expiration
MINIVELLE's oppositions filed in EPO
MINIVELLE Litigations
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US6024976 | NOVEN | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
Jan, 2014
(10 years ago) | |
| US5656286 | NOVEN | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
Aug, 2014
(9 years ago) | |
| US5646286 | NOVEN | Palladium catalyzed vinylic substitution reactions with 2-substituted-pyridines |
Aug, 2014
(9 years ago) | |
| US9724310 | NOVEN | Transdermal estrogen device and delivery |
Jul, 2028
(4 years from now) | |
| US8231906 | NOVEN | Transdermal estrogen device and delivery |
Jul, 2030
(6 years from now) | |
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6841716 | NOVEN | Patch |
Apr, 2020
(4 years ago) | |
| US9730900 | NOVEN | Transdermal estrogen device and delivery |
Jul, 2028
(4 years from now) | |
| US9833419 | NOVEN | Transdermal estrogen device and delivery |
Jul, 2028
(4 years from now) | |
Drugs and Companies using ESTRADIOL ingredient
Market Authorisation Date: 23 September, 2014
Treatment: A method for administering estradiol comprising a monolithic transdermal drug delivery system consisting of (i) a backing layer and (ii) a single adhesive polymer matrix layer as claimed in us patent ...
Dosage: FILM, EXTENDED RELEASE;TRANSDERMAL
How can I launch a generic of MINIVELLE before it's drug patent expiration?
More Information on Dosage
MINIVELLE family patents
